MUMBAI, India, July 24 -- Intellectual Property India has published a patent application (202611056903 A) filed by Abhimanyu Kumar Jha; Tripti Gangwar; Akshita Malik; Nistha Agarwal; Radhey Shyam Sharma; Sushma Chauhan; Meenakshi Jha; and Vijay Mohan on May 05, 2026, for Triphala Extract Formulation For Antioxidant Detoxification And Adjunct Breast Cancer Treatment.
Inventors include Abhimanyu Kumar Jha; Tripti Gangwar; Akshita Malik; Nistha Agarwal; Radhey Shyam Sharma; Sushma Chauhan; Meenakshi Jha; and Vijay Mohan.
The application for the patent was published on July 17, 2026, under issue no. 29/2026.
Abstract: The present invention relates to a Triphala extract formulation for antioxidant detoxification and adjunct breast cancer treatment. The formulation comprises standardized extracts of Emblica officinalis, Terminalia chebula, and Terminalia bellirica with enhanced bioavailability and stability. The invention provides antioxidant support, reduces treatment-induced oxidative stress, and improves therapeutic outcomes in breast cancer management.
Disclaimer: Curated by HT Syndication.
